Department of Pediatrics

Findings from Rutgers Health and other researchers may lead to more precise treatment.

Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an engineered immune cell therapy can halt the progression of the autoimmune disease.

Rutgers Health researchers and others find hundreds of young patients receive potentially dangerous medication combinations, raising concerns about prescription practices.